3 Indian Stocks Trading Below Fair Value on Cash Flow
US 10 year yields have moved back toward multi year highs as investors focus on inflation risks and energy costs. When borrowing costs stay elevated, many traders concentrate on headline growth stories and overlook steady cash generators. That can leave solid companies trading below their estimated fair value. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that currently screen as potential value opportunities.
The stocks covered below are just a small sample, and the full screen surfaced 27 more companies with equally compelling cash flow stories that are not included here. If you want to go beyond this starter list, head straight to the Undervalued Stocks Based On Cash Flows screener to identify and analyze the ideas that best fit your own value approach.
Entero Healthcare Solutions (NSEI:ENTERO)
Overview: Entero Healthcare Solutions is a Mumbai based distributor that connects pharmaceutical and surgical manufacturers with pharmacies, hospitals, clinics, and healthcare practitioners across India, supplying everything from medicines and vaccines to medical devices and hospital consumables, and also offering private label products and distribution services.
Operations: Entero Healthcare Solutions generates all of its approximately ₹71.3 billion in revenue from trading pharmaceutical and surgical products in India.
Market Cap: ₹61.7 billion
Entero Healthcare Solutions sits at the heart of India’s growing healthcare supply chain, with Q1 FY2026 revenue of ₹19,435.02 million and a full year FY2026 revenue base of ₹66,104.49 million supporting its role as a large scale distributor. The stock currently screens as materially below an estimated cash flow value of ₹2,796.57 and analysts see earnings rising faster than revenue, which points to efficiency gains as recent tech investments and a shift toward higher margin segments start to matter more. The catch is that Entero still leans heavily on acquisitions and external borrowing, so investors need to watch integration risks, working capital and competition from digital players. If execution holds, this mix of scale, growth and valuation could be hard to ignore.
Entero Healthcare Solutions looks like an efficiency story that the market has not fully priced in yet, given its scale and focus on higher margin segments. See how the cash flow gap stacks up in the DCF valuation analysis for Entero Healthcare Solutions and where acquisition risks might change the picture.
Build your own cash flow shortlist around Entero Healthcare Solutions
Entero Healthcare Solutions and the two other stocks in this article all came from a single screener, but the real edge comes when you design your own filters. Use our flexible Screener to mix valuation, growth and balance sheet criteria that fit your style, or tap into ready made themes through our Investing Ideas.
Mangalore Refinery and Petrochemicals (BSE:500109)
Overview: Mangalore Refinery and Petrochemicals is an Indian refiner that processes crude oil into fuels such as diesel, petrol, aviation fuel and LPG, as well as petrochemical products like polypropylene, which it sells in India and overseas as part of the Oil and Natural Gas Corporation group.
Operations: Mangalore Refinery and Petrochemicals generates about ₹1,095.6 billion in revenue from its downstream petroleum segment.
Market Cap: ₹298.9 billion
Mangalore Refinery and Petrochemicals stands out on this cash flow screener because the stock is flagged as trading well below estimated fair value. The business has just swung from a loss to a ₹9,456.8 million profit in Q1 FY2026-27. The company is adding an ATF pipeline to Bengaluru airport and expanding its retail outlets, which could shift more volume into higher margin channels if conditions stay supportive. At the same time, heavy reliance on imported crude, debt that is not yet comfortably covered by operating cash flow and exposure to long term fuel demand shifts mean the margin story is not risk free. If you are weighing value against these structural questions, this is a refinery worth a closer look.
Mangalore Refinery and Petrochemicals appears to be a valuation story obscured by refinery cycle noise and a recent swing to profit, yet the real twist for this stock sits inside the analysis report for Mangalore Refinery and Petrochemicals
Balrampur Chini Mills (NSEI:BALRAMCHIN)
Overview: Balrampur Chini Mills is a Kolkata headquartered sugar producer that also runs distilleries, bioplastics and green chemicals projects, fertilizer operations, and a 175.7 megawatt power business, while exporting part of its sugar output.
Market Cap: ₹132.0 billion
Balrampur Chini Mills is attracting attention because it combines a traditional sugar and ethanol base with a push into PLA bioplastics and other green chemicals, which could reshape how its earnings mix looks over time. Analysts expect strong revenue and earnings growth, supported by government ethanol programs and efforts to improve cane yields and recovery, yet recent quarterly net income softness and a net margin of 5.8% show that execution still matters. Heavy reliance on external borrowing for a large PLA project also raises questions about cash flow and dividend coverage. If you are looking for a company tied to India’s consumption and sustainability themes, but with clear policy and funding risks, this is a story worth watching closely.
Balrampur Chini Mills sits at the crossroads of sugar, ethanol and PLA bioplastics, yet the full investment picture is still easy to miss. See how the story changes once you factor in the analyst forecasts for Balrampur Chini Mills
Curious About What You Might Be Missing Next
Fresh stock ideas can move from quiet accumulation to full breakout before most investors notice. Do not get caught chasing momentum after it is flying. Act now.
- Spot companies quietly building momentum before headlines catch up by scanning the 617 high quality undiscovered gems curated for strong fundamentals still under the radar for now.
- Target resilient cash generators that may hold up when sentiment turns by reviewing the 303 resilient stocks with low risk scores focused on durable earnings and sturdy balance sheets.
- Ride long term infrastructure and electrification trends while they are still pricing in early growth by reviewing the 38 power grid technology and infrastructure stocks filtered for critical grid and technology players.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com